Study S001275

Does the Preoperative Use of GLP-1 Agonists Change Outcomes in Patients Waiting for Total Hip and Knee Arthroplasty: A Pilot Randomized Control Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07755085
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-10-01
Primary completion: 2028-06-01
Lead sponsor: Nova Scotia Health Authority
Conditions: Arthritis; Obesity & Overweight; GLP - 1
Interventions: DRUG:GLP-1 Receptor Agonists + Behavioral modification; BEHAVIORAL:Behavioral + placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Incidence of Wound Complication after Joint Arthroplasty [90 days]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0004048	The Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists. Lavu MS, The Journal of arthroplasty	2024	Nonrandomized study	PMID 38857711 DOI	registry reference BACKGROUND:38857711